Potential therapeutic targets for neurokinin-1 receptor antagonists
about
TRPV1 and SP: key elements for sepsis outcome?A role for fMRI in optimizing CNS drug development.Role of G protein-coupled receptors in inflammation.Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens.Serum substance P levels are associated with severity and mortality in patients with severe traumatic brain injury.Emerging peripheral receptor targets for deep-tissue craniofacial pain therapies.Substance P as a novel anti-obesity targetMechanisms of Disease: genetics of fibromyalgia.Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIVIrritable bowel syndrome and migraine: bystanders or partners?Pathophysiological and neurochemical mechanisms of postoperative nausea and vomitingTachykinin receptor antagonists in clinical trials.Neurokinin-1 receptor is a novel positive regulator of Wnt/ β-catenin signaling in melanogenesis.Neurokinin-1 receptor antagonists: a comprehensive patent survey.Peripheral mechanisms of dental pain: the role of substance P.Effect of sevoflurane anesthesia on the comprehensive mRNA expression profile of the mouse hippocampusSymptom severity and distress in advanced cancer.An update and systematic review on drug therapies for the treatment of refractory chronic cough.
P2860
Q27015036-CE5E61D7-15A2-4D3E-9A51-52162743A5B6Q31036354-69818078-282C-432A-96F0-98B479E62A7BQ33858841-EB541F9E-F337-480A-A4BC-EEAE737AA2BCQ34504753-983541DC-9EE3-434B-95EB-DA9004C44CEBQ35584890-DE3933EE-FEA5-47EA-89AC-A7AFE979EEECQ35866479-1DF9C81E-5E9C-417F-B651-56B368B9933DQ36607177-2C932C28-89E6-435B-A690-CCC2C3523B36Q36667812-C555D29D-93F3-4B37-B91A-FD9FCBA85F9DQ36937565-628156D2-43CC-46E4-BCEC-539A8DDC3696Q37022341-7F267617-B07B-47EB-813E-8D916128C766Q37559641-9545BAB9-CDEB-4D58-A0E6-1A6C721AC961Q37638682-CBDC0666-E848-488F-8076-66F57BB94183Q37697149-D9F0E0E8-D76E-4D6A-8925-06CFE4601E93Q37763716-696E3A47-3590-46A4-9956-1C80AF02191BQ37999781-639ED8AE-B988-4789-92AA-F2D992C0BD9CQ41844907-B16E3FEC-1DB2-4D22-BB7E-591266E2084CQ43869502-0118F222-3250-4094-86A4-57502988A6EEQ52586592-F66348D8-3C9E-48EA-B885-8C9E8230EE3C
P2860
Potential therapeutic targets for neurokinin-1 receptor antagonists
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Potential therapeutic targets for neurokinin-1 receptor antagonists
@ast
Potential therapeutic targets for neurokinin-1 receptor antagonists
@en
Potential therapeutic targets for neurokinin-1 receptor antagonists
@nl
type
label
Potential therapeutic targets for neurokinin-1 receptor antagonists
@ast
Potential therapeutic targets for neurokinin-1 receptor antagonists
@en
Potential therapeutic targets for neurokinin-1 receptor antagonists
@nl
prefLabel
Potential therapeutic targets for neurokinin-1 receptor antagonists
@ast
Potential therapeutic targets for neurokinin-1 receptor antagonists
@en
Potential therapeutic targets for neurokinin-1 receptor antagonists
@nl
P2860
P3181
P1476
Potential therapeutic targets for neurokinin-1 receptor antagonists
@en
P2093
Ruth A Duffy
P2860
P3181
P356
10.1517/14728214.9.1.9
10.1517/EOED.9.1.9.32956
P407
P577
2004-05-01T00:00:00Z